NAARI PTE
GenericsNAARI PTE is a generic drug manufacturer focused on Dermatology.
NAARI PTE's Key Drugs
NAARI PTE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
NAARI PTE's Recent FDA Approvals
New NDA/BLA approvals for NAARI PTE over the last two years — novel drugs only, excluding generics and label supplements.
NAARI PTE's Therapeutic Areas
NAARI PTE's approved drugs and pipeline span 1 therapeutic area, led by Dermatology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
NAARI PTE's Top Competitors
NAARI PTE's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
NAARI PTE Pipeline Snapshot
Active clinical trials for NAARI PTE across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2015-04-07
- Latest
- 2024-12-09
- Applications
- 18